Skip to Content Skip to Footer

The Institutional Biosafety Committee (IBC) was established under the provisions of the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines). The role of the IBC is to establish and implement policies that provide for the safe conduct of recombinant DNA research and to ensure compliance with the NIH Guidelines. In addition, the IBC oversees research involving infectious agents and toxic biological molecules. The IBC also reviews research protocols from grant applications submitted to extramural funding agencies to confirm that experiments will be conducted safely and in compliance with the NIH Guidelines. Members of the IBC are appointed by the Vice President for Research and Biotechnology and include persons who are not otherwise affiliated with the University to represent the interests of the surrounding community with respect to health and protection of the environment.

All communication should be directed to the IBC office at:

  • Resources

    National Institutes of Health (NIH)

    Centers for Disease Control (CDC)

    Biosafety in Microbiological and Biomedical Laboratories

    Federal Select Agent Regulations:

    Possession, Use and Transfer of Select Agents and Toxins

    Health and Human Services Regulations:

    Department of Labor Occupational Safety & Health Administration (OSHA)

    U.S. Department of Agriculture (USDA-APHIS)